PET myokardial fedtsyrestofskifte-billeddannelse med XTR003-injektion og 18F-FDG til vurdering af myokardielevabilitet ved iskæmisk kardiomyopati (STB-XTR-003)
Et randomiseret, åbent, parallellkontrolleret fase IIb klinisk forsøg med PET-myokardiel fedtsyre-metabolsk billeddannelse med XTR003-injektion integreret med 18F-FDG til vurdering af myokardiel levedygtighed hos patienter med iskæmisk kardiomyopati
This is a prospective, multicenter, randomized, open-label, parallel-controlled Phase IIb study to investigate the diagnostic-prognostic utility of XTR003 Injection integrated with 18F-FDG as an exploratory clinical trial. A total of 40-60 patients will be enrolled and randomized into two study groups as: fasting XTR003/18F-FDG group and glucose-loaded group at a 1:1 ratio. Each group will receive resting myocardial perfusion imaging (MPI) combined with metabolic PET imaging to evaluate myocardial metabolic activity and myocardial viability. Segmental perfusion abnormality, metabolic activity and myocardial viability will be analyzed according to the standard approaches in Nuclear Cardiology. Regional and global left ventricular function will be assessed with cardiac MRI and echocardiography prior to and post the completion of full revascularization within 6-month time point. A repeated resting MPI will also be performed to assess the improvement of perfusion abnormality.
All study subjects will undergo 6 months follow-up for major adverse cardiac events (MACE).
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 2
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Tao Liu
- Telefonnummer: +86-18101131863
- E-mail: tao.liu1@sinotau.com
Studiesteder
-
-
-
Beijing, Kina
- Ikke rekrutterer endnu
- Beijing Chaoyang Hospital, Capital Medical University
-
Tianjin, Kina
- Ikke rekrutterer endnu
- TEDA International Cardiovascular Hospital
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina
- Rekruttering
- Beijing Anzhen Hospital, Capital Medical University
-
Kontakt:
- Xu Ke Yang
- Telefonnummer: +86-010-64426153
- E-mail: EC@anzhenGCP.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Aged 18 to 85 years, regardless of gender.
- Diagnosed with ischemic cardiomyopathy (ICM).
- significant coronary artery disease (CAD).
- Left ventricular systolic dysfunction, with LVEF ranging from >20% to ≤40%
- Assessed by a team of cardiac surgeons/operators as suitable for complete revascularization.
- Capable of effective communication with the investigators, able to understand and comply with the clinical study requirements, voluntarily participate in the study, and provide written informed consent after being fully informed.
Exclusion Criteria:
- Decompensated heart failure within 48 hours prior to enrollment.
- Recent ST-segment elevation myocardial infarction (STEMI) within less than 4 weeks.
- Left ventricular aneurysm.
- Judged by the investigator as unable to complete PET examination.
- Severe renal insufficiency.
- Severe hepatic insufficiency.
- Subjects with fever or active infectious diseases who are assessed by the investigator as unsuitable for study participation.
- Pregnant or lactating women.
- Contraindications to magnetic resonance imaging (MRI), such as claustrophobia or intracorporeal metallic implants.
- Subjects with mental disorders or poor compliance.
- Significant occupational exposure to ionizing radiation (e.g., exceeding 50 mSv per year) or exposure to radioactive substances/ionizing radiation for therapeutic or research purposes within the past 10 years.
- Other circumstances deemed by the investigator as unsuitable for trial participation.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Fasting XTR003/ ¹⁸F-FDG PET
Fasting XTR003 and ¹⁸F-FDG PET combined with myocardial metabolic imaging |
Fasting XTR003 / ¹⁸F-FDG PET myocardial metabolic imaging |
|
Aktiv komparator: Glucose-modulated ¹⁸F-FDG PET
Glucose-modulated ¹⁸F-FDG PET Myocardial Metabolic Imaging |
Glucose loaded ¹⁸F-FDG PET Myocardial Metabolic Imaging |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
the sensitivity and specificity of the experimental group and control group
Tidsramme: 6 months
|
Using the recoverable left-ventricular wall motion abnormality at 6 months post full revascularization as the reference standard to study the sensitivity and specificity of myocardial viability for predicting functional recovery in the experimental group and control group. |
6 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Ændringer i New York Heart Association Funktionsklassificering (NYHA)
Tidsramme: 6 måneder
|
6 måneder
|
|
|
Varighed påkrævet for PET myokardiel metabolisk billeddannelse i de to grupper (min)
Tidsramme: dag 1
|
dag 1
|
|
|
PET Myokardiel Metabolisk Billeddannelseskvalitet
Tidsramme: dag 1
|
dag 1
|
|
|
Restende MPI af perfusionsabnormitet
Tidsramme: 6 måneder
|
6 måneder
|
|
|
Store uønskede hjerte-karhændelser (MACE)
Tidsramme: 6 måneder
|
6 måneder
|
|
|
Myocardial perfusion-metabolism imaging parameters (segmental level)
Tidsramme: 6 months
|
include the following three items:
|
6 months
|
|
Changes in left ventricular function parameters measured by cardiac magnetic resonance before and after revascularization
Tidsramme: 6 months
|
Left ventricular ejection fraction (LVEF, %) |
6 months
|
|
Changes in left ventricular function parameters measured by cardiac magnetic resonance before and after revascularization
Tidsramme: 6 months
|
Left ventricular end-diastolic diameter (LVEDD) |
6 months
|
|
Changes in left ventricular function parameters measured by cardiac magnetic resonance before and after revascularization
Tidsramme: 6 months
|
Left ventricular end-systolic diameter (LVESD) |
6 months
|
|
Changes in left ventricular function parameters measured by cardiac magnetic resonance before and after revascularization
Tidsramme: 6 months
|
Left ventricular end-diastolic volume (LVEDV, mL) |
6 months
|
|
Changes in left ventricular function parameters measured by cardiac magnetic resonance before and after revascularization
Tidsramme: 6 months
|
Left ventricular end-systolic volume (LVESV, mL) |
6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- STB-XTR003-202
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .